EE200300218A - Latentse antitrombiin III valmistamise meetod - Google Patents

Latentse antitrombiin III valmistamise meetod

Info

Publication number
EE200300218A
EE200300218A EEP200300218A EEP200300218A EE200300218A EE 200300218 A EE200300218 A EE 200300218A EE P200300218 A EEP200300218 A EE P200300218A EE P200300218 A EEP200300218 A EE P200300218A EE 200300218 A EE200300218 A EE 200300218A
Authority
EE
Estonia
Prior art keywords
preparation
antithrombin iii
latent antithrombin
latent
iii
Prior art date
Application number
EEP200300218A
Other languages
English (en)
Estonian (et)
Inventor
Karlsson G�ran
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0004086A external-priority patent/SE0004086D0/xx
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of EE200300218A publication Critical patent/EE200300218A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EEP200300218A 2000-11-08 2001-11-08 Latentse antitrombiin III valmistamise meetod EE200300218A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0004086A SE0004086D0 (sv) 2000-11-08 2000-11-08 Preparation process
US25214800P 2000-11-20 2000-11-20
PCT/SE2001/002473 WO2002038610A1 (en) 2000-11-08 2001-11-08 Process for the preparation of latent antithrombin iii

Publications (1)

Publication Number Publication Date
EE200300218A true EE200300218A (et) 2003-08-15

Family

ID=26655296

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300218A EE200300218A (et) 2000-11-08 2001-11-08 Latentse antitrombiin III valmistamise meetod

Country Status (15)

Country Link
EP (1) EP1332159A1 (cs)
JP (1) JP2004522707A (cs)
KR (1) KR20030057545A (cs)
AU (1) AU2002214468A1 (cs)
BR (1) BR0115188A (cs)
CA (1) CA2428055A1 (cs)
CZ (1) CZ20031277A3 (cs)
EE (1) EE200300218A (cs)
HU (1) HUP0301766A3 (cs)
IL (1) IL155539A0 (cs)
MX (1) MXPA03004030A (cs)
NO (1) NO20032048D0 (cs)
PL (1) PL360410A1 (cs)
RU (1) RU2003117016A (cs)
WO (1) WO2002038610A1 (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
SE0203770D0 (sv) * 2002-12-19 2002-12-19 Biovitrum Ab Method of separation
ES2426172T3 (es) 2005-02-07 2013-10-21 Hanuman Llc Dispositivo concentrador de plasma
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
JP5479319B2 (ja) 2007-04-12 2014-04-23 バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー ブイ式懸濁液分画システム
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
EP2567692B1 (en) 2008-02-27 2016-04-06 Biomet Biologics, LLC Use of a device for obtaining interleukin-1 receptor antagonist rich solutions
WO2009111338A1 (en) 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device

Also Published As

Publication number Publication date
HUP0301766A2 (hu) 2003-08-28
EP1332159A1 (en) 2003-08-06
RU2003117016A (ru) 2004-12-10
CZ20031277A3 (cs) 2003-08-13
MXPA03004030A (es) 2004-02-12
CA2428055A1 (en) 2002-05-16
KR20030057545A (ko) 2003-07-04
BR0115188A (pt) 2004-02-03
IL155539A0 (en) 2003-11-23
PL360410A1 (en) 2004-09-06
AU2002214468A1 (en) 2002-05-21
NO20032048L (no) 2003-05-07
WO2002038610A1 (en) 2002-05-16
NO20032048D0 (no) 2003-05-07
HUP0301766A3 (en) 2005-12-28
JP2004522707A (ja) 2004-07-29

Similar Documents

Publication Publication Date Title
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
EE200300218A (et) Latentse antitrombiin III valmistamise meetod
NO20031505D0 (no) Sementskomontasje for monoboret brönn
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
DE60108010D1 (de) Toner
FI20002836L (fi) Menetelmä oskillaattorin säätämiseksi
CY2013011I1 (el) Μεθοδος χορηγησης διφωσφονικων
DE50115520D1 (de) Strahlformungsverfahren
DE60029553D1 (de) Schätzungsmethode
FI20011621A0 (fi) Menetelmä sitalopraamin valmistamiseksi
FI20012271L (fi) Menetelmä vastinpisteiden määrittämiseksi
EE200100383A (et) L-fenüülefriinvesinikkloriidi valmistamise meetod
EE200300294A (et) Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod
DK1263717T3 (da) Fremgangsmåde til fremstilling af methionin
IS6716A (is) Aðferðir við að framleiða sílostasól
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
DE50103892D1 (de) Navigationsverfahren
FI20002262A0 (fi) Menetelmä proteiinin rakenteen muuttamiseksi
BR0104265B1 (pt) Método de revelação eletrostatográfica
NO20023702D0 (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20025385D0 (no) FremgangsmÕte for fremstilling av sulfonylbenzoylguanidiniumsalter
ITMI20000334A0 (it) Procedimento di preparazione di miscele cementizie
FI4813U1 (fi) Seinäkesäilytin
FI20000535A0 (fi) Menetelmä kuparin valmistamiseksi